山东大学耳鼻喉眼学报 ›› 2019, Vol. 33 ›› Issue (1): 103-108.doi: 10.6040/j.issn.1673-3770.1.2018.032

• 论著 • 上一篇    下一篇

慢性鼻-鼻窦炎伴鼻息肉合并哮喘患者肺功能分析

王建伟,张宇,宋西成   

  1. 青岛大学附属烟台毓璜顶医院耳鼻咽喉头颈外科, 山东 烟台 264000
  • 出版日期:2019-01-20 发布日期:2019-01-28
  • 作者简介:王建伟. E-mail:wangjianweiokk@126.com

Analysis of pulmonary function of patients who developed chronic rhinosinusitis with nasal polyps and asthma

WANG Jianwei, ZHANG Yu, SONG Xicheng   

  1. Department of Otorhinolaryngology Head and Neck Surgery, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong, China
  • Online:2019-01-20 Published:2019-01-28

HTML

PDF (PC)

275

摘要： 目的 分析慢性鼻-鼻窦炎伴鼻息肉(CRSwNP)合并哮喘患者肺功能情况。 方法 选取74例经鼻内镜手术(FESS)的CRSwNP合并哮喘患者,分组进行肺功能比较:男49例(男性组),女25例(女性组);吸烟32例(吸烟组),不吸烟42例(非吸烟组);血清特异性IgE阳性者27例(IgE组),阴性者47例(非IgE组);外周血嗜酸粒细胞升高(外周血嗜酸粒细胞绝对值>0.5×109/L)者27例(外周血嗜酸粒细胞升高组),未升高者47例(外周血嗜酸粒细胞非升高组);术后送检鼻息肉组织嗜酸粒细胞升高(嗜酸粒细胞平均>10个/HPF)者31例(组织嗜酸粒细胞升高组),未升高者43例(组织嗜酸粒细胞非升高组)。所有肺功能检测均在具有上岗资质变态反应科专业医师指导下完成,检测数据由德国康讯肺功能仪(PowerCubeBody)采集,肺功能指标包括第1秒用力呼气容积(FEV1)占预计值的百分比(FEV1% pre)、FEV1与用力肺活量(FVC)的比值占预计值的百分比(FEV1/FVC% pre)、最大通气量(MVV)占预计值的百分比(MVV% pre)、用力呼出50%肺活量时的瞬间呼气流(FEF50%)、用力呼出75%肺活量时的瞬间呼气流(FEF75%)及最大呼气中期流量(MMEF)。74例患者评估肺功能下降程度后针对性给予雾化吸入治疗,2~3次/d,沙美特罗替卡松粉吸入剂1吸,2次/d,予孟鲁司特钠 10 mg/d,氯雷他定10 mg/d口服,同时给予盐酸氮卓斯汀鼻喷剂 2次/d+布地奈德鼻喷雾剂 2次/d喷鼻治疗。自入院至术前,患者行药物治疗时间为1~14 d。所有患者术前30 min雾化吸入1次,麻醉前行沙美特罗替卡松粉吸入剂1吸。对术前药物干预后肺功能改善情况进行判定。 结果 74例患者均顺利完成手术。入院时女性组FEF50%、FEF75%及MMEF低于男性组(t分别为3.213、2.829、3.644,P分别为0.002 0、0.006 1、0.000 5),吸烟组较非吸烟组、外周血及鼻息肉组织中嗜酸粒细胞升高组均较非升高组FEV1/FVC% pre下降(t分别为2.032、2.259、2.634,P分别为0.045 8、0.029 2、0.010 3),同时鼻息肉组织嗜酸粒细胞升高组较非升高组MVV% pre降低(t=2.453, P=0.0166)。经术前规范药物干预后,患者肺功能指标FEV1%pre、FEV1/FVC% pre、MVV% pre、FEF50%、FEF75%及MMEF均较入院时改善(t分别为6.640、6.071、8.166、5.554、6.137、4.256, P均为0.000 0)。 结论 CRSwNP合并哮喘患者中,女性较男性更易伴发小气道功能障碍;吸烟、外周血及鼻息肉组织嗜酸粒细胞升高亦可影响肺功能;规范的术前药物干预可有效改善CRSwNP合并哮喘患者的肺功能,减少围术期哮喘急性发作风险,有助于手术顺利实施。

关键词: 鼻-鼻窦炎伴鼻息肉, 哮喘, 肺功能, 药物干预

Abstract: Objective To analyze the pulmonary function of patients who developed chronic rhinosinusitis with nasal polyps(CRSwNP). Methods The pulmonary function of 74 patients who underwent functional endoscopic sinus surgery(FESS)was measured and analyzed. The patients were divided into comparable groups under different criteria: male(49 patients)and female(25 patients)groups, smoking(32 patients)and non-smoking(42 patients)groups, serum-specific immunoglobulin E(IgE)-positive(27 patients)and serum-specific IgE-negative(47 patients)groups, elevated eosinophils in peripheral blood(27 patients)and non-elevated eosinophils in peripheral blood(47 patients)groups, and elevated eosinophils in nasal polyps(31 patients)and non-elevated eosinophils in nasal polyps(43 patients)groups. The pulmonary function of all the patients were completed under guidance of a professional allergist with qualifications; test data were collected using the German GANSHORN Pulmonary Function Instrument(PowerCube-Body). Analyzed indices of pulmonary function included the percentage of forced expiratory volume in the first second(FEV1%pre), percentage of predicted value of the ratio of FEV1 to forced vital capacity(FVC)(FEV1/FVC% pre), percentage of maximum ventilatory volume estimated(MVV% pre),forced expiratory flow at 50% of FVC(FEF50%), forced expiratory flow at 75% of FVC(FEF75%), and maximal mid-expiratory flow(MMEF). After pulmonary function was evaluated, all 74 patients accepted individualized specific aerosol inhalation twice or thrice a day, combined with one inhalation of salmeterol xinafoate and fluticasone propionate powder twice a day. In addition, 10 mg of oral montelukast sodium and loratadine were administered once a day separately, along with a nasal spray of azelastine hydrochloride and budesonide twice a day. The medical therapy persisted for 1-14 days from admission to preoperation, and the patients were administered another aerosol inhalation 30 min before surgery and one inhalation of salmeterol xinafoate and fluticasone propionate powder before general anesthesia. The improvement in pulmonary function after medical treatment was also evaluated. Results All 74 patients underwent FESS unremarkably. On admission, FEF50%, FEF75%, and MMEF in the female group were lower than in the male group(t=3.213, 2.829, and 3.644, respectively; P=0.002 0, 0.006, and 0.000 5, respectively); FEV1/FVC% pre was lower in the smoking group than in the non-smoking group(t=2.032, P=0.045 8), in the elevated eosinophils in peripheral blood group than in the non-elevated eosinophils in peripheral blood group(t=2.259, P=0.029 2), and in the elevated eosinophils in nasal polyps group than in the non-elevated eosinophils in nasal polyps group(t=2.634, P=0.010 3); and MVV% pre decreased significantly in the elevated eosinophils in nasal polyps group compared to in the non-elevated eosinophils in nasal polyps group(t=2.453, P=0.016 6). Pulmonary function indices including FEV1%pre, FEV1/FVC% pre, MVV% pre, FEF50%, FEF75%, and MMEF improved significantly after standardized medical treatment(P=0.000 0). Conclusion Female patients are more likely to develop small airway dysfunction compared to male patients among those who develop CRSwNP and asthma. Smoking and elevated eosinophils in peripheral blood and in nasal polyps may also influence pulmonary function. Standardized preoperative medical treatment is efficient in improving the pulmonary function of patients with CRSwNP and asthma and in decreasing the potential of acute attacks of asthma. Therefore, unremarkable surgeries are guaranteed.

Key words: Chronic rhinosinusitis with nasal polyps, Asthma, Pulmonary function, Medical treatment

中图分类号: 

  • R765.41
[1] 陈枫虹, 徐睿, 左可军, 等. 慢性鼻-鼻窦炎伴支气管哮喘患者内镜手术综合治疗疗效观察[J]. 中华耳鼻咽喉头颈外科杂志, 2011, 46(6):444-448. doi:10.3760/cma.j.issn.1673-0860.2011.06.002. CHEN Fenghong, XU Rui, ZUO Kejun, et al. Efficacy of endoscopic sinus surgery-based on multidisciplinary treatment for chronic rhinosinusitis with asthma[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2011, 46(6):444-448. doi:10.3760/cma.j.issn.1673-0860.2011.06.002.
[2] Song WJ, Kang MG, Chang YS, et al. Epidemiology of adult asthma in Asia: toward a better understanding[J]. Asia Pac Allergy, 2014, 4(2):75-85. doi:10.5415/apallergy.2014.4.2.75.
[3] 李华斌, 赖玉婷. 慢性鼻-鼻窦炎的发病机制及诊疗进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(3):4-9. LI Huabin, LAI Yuting. Pathogenesis, diagnosis, and treatment of chronic rhinosinusitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(3):4-9.
[4] 韩传宝, 周钦海, 孙培莉, 等. 哮喘患者围术期麻醉管理[J]. 临床麻醉学杂志, 2013, 29(8):820-822.
[5] Kariya S, Okano M, Higaki T, et al. Chronic rhinosinusitis patients have decreased lung function[J]. Int Forum Allergy Rhinol, 2014, 4(10):828-833. doi:10.1002/alr.21370.
[6] Yamada H, Masuko H, Yatagai Y, et al. Role of lung function genes in the development of asthma[J]. PLoS One, 2016, 11(1):e0145832. doi:10.1371/journal.pone.0145832.
[7] 中华医学会耳鼻咽喉头颈外科学分会鼻科学组.慢性鼻-鼻窦炎诊断和治疗指南(2012年,昆明)[J].中国医刊,2013,48(11):103-105. doi:10.3969/j.issn.1008-1070.2013.11.049.
[8] 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2016年版)[J].中华结核和呼吸杂志,2016,39(9):675-697. doi:10.3760/cma.j.issn.1001-0939.2016.09.007.
[9] Stevens WW, Peters AT, Suh L, et al. A retrospective, cross-sectional study reveals that women with CRSwNP have more severe disease than men[J]. Immun Inflamm Dis, 2015, 3(1):14-22. doi:10.1002/iid3.46.
[10] Toskala E, Kennedy DW. Asthma risk factors[J]. Int Forum Allergy Rhinol, 2015, 5(Suppl 1):S11-S16. doi:10.1002/alr.21557.
[11] Ardehali MM, Amali A, Bakhshaee M, et al. The comparison of histopathological characteristics of polyps in asthmatic and nonasthmatic patients[J]. Otolaryngol Head Neck Surg, 2009, 140(5):748-751. doi:10.1016/j.otohns.2009.01.027.
[12] Han DH, Kim SW, Cho SH, et al. Predictors of bronchial hyperresponsiveness in chronic rhinosinusitis with nasal polyp[J]. Allergy, 2009, 64(1):118-122. doi:10.1111/j.1398-9995.2008.01841.x.
[13] Zhao JL, Li M, Chen JK, et al. Smoking status and gene susceptibility play important roles in the development of chronic obstructive pulmonary disease and lung function decline: A population-based prospective study[J]. Medicine(Baltimore), 2017, 96(25):e7283. doi:10.1097/MD.0000000000007283.
[14] Bird Y, Staines-Orozco H. Pulmonary effects of active smoking and secondhand smoke exposure among adolescent students in Juárez, Mexico[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11:1459-1467. doi:10.2147/COPD.S102999.
[15] Langdon C, Mullol J. Nasal polyps in patients with asthma: prevalence, impact, and management challenges[J]. J Asthma Allergy, 2016, 9:45-53. doi:10.2147/JAA.S86251.
[16] Incorvaia C, Riario-Sforza GG. Allergy testing in the diagnosis of asthma[J]. Lancet Respir Med, 2015, 3(5):e16. doi:10.1016/S2213-2600(15)00089-2.
[17] 中华医学会呼吸病学分会哮喘学组.支气管哮喘控制的中国专家共识[J].中华内科杂志,2013,52(5):440-443. DOI:10.3760/cma.j.issn.0578-1426.2013.05.021. Asthma Group of the Respiratory Disease Branch of Chinese Medical Association.Chinese expert consensus onasthma control [J]. Chinese Journal of Internal Medicine, 2013, 52(5):440-443.DOI:10.3760/cma.j.issn.0578-1426.2013.05.021.
[18] 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南(第二部分): 肺量计检查[J]. 中华结核和呼吸杂志, 2014, 37(7):481-486. doi:10.3760/cma.j.issn.1001-0939.2014.07.001.
[19] 陈国静, 蔡晓岚, 李学忠, 等. 慢性鼻-鼻窦炎-鼻息肉伴哮喘患者鼻内镜围手术期药物治疗[J]. 山东大学耳鼻喉眼学报, 2015, 29(3):35-38. CHEN Guojing, CAI Xiaolan, LI Xuezhong, et al. Perioperative treatment in endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps and asthma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2015, 29(3):35-38.
[20] 廖华, 沈莹, 王鹏举. 慢性鼻-鼻窦炎伴鼻息肉患者鼻阻力与肺功能检测及临床分析[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29(9):784-787,799. doi:10.13201/j.issn.1001-1781.2015.09.004. LIAO Hua, SHEN Ying, WANG Pengju. Clinical analysis of nasal resistance and pulmonary function testing in patients with chronic nasal-sinusitis and nasal polyps[J]. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2015, 29(9):784-787,799. doi:10.13201/j.issn.1001-1781.2015.09.004.
[21] Rix I, Håkansson K, Larsen CG, et al. Management of chronic rhinosinusitis with nasal polyps and coexisting asthma: A systematic review[J]. Am J Rhinol Allergy, 2015, 29(3):193-201. doi:10.2500/ajra.2015.29.4178.
[22] 黄凯丰. 糖皮质激素短疗程雾化吸入对嗜酸粒细胞性鼻窦炎伴鼻息肉患者鼻部症状及肾上腺皮质功能的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(4):28-31. doi:10.6040/j.issn.1673-3770.0.2017.170. HUANG Kaifeng. Effect of short-term glucocorticoid inhalation on nasal symptoms and adrenocortical function in patients with eosinophilic chronic sinusitis accompanied by nasal polyps[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(4):28-31. doi:10.6040/j.issn.1673-3770.0.2017.170.
[23] 李婷婷, 鞠建宝, 于海玲, 等. 慢性鼻-鼻窦炎伴鼻息肉并哮喘围手术期规范化治疗[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 30(7):612-615. LI Tingting, JUJIANBAO, YU Hailing, et al. The standardized perioperative treatment of chronic rhinosinusitis with nasal polyps and asthma[J]. Journal of Clinical Otorhinolaryngology, 2015, 30(7):612-615.
[1] 张宇,宋西成. 慢性鼻窦炎伴鼻息肉与哮喘的相关性机制及治疗策略研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 49-52.
[2] 杜经纬,冯俊,马鹏,李志勇,李红光. 鼻腔冲洗联合鼻用糖皮质激素对AR患者FeNO、肺功能及生活质量的影响[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 124-127.
[3] 朱政,王万钧,胡秋蓉,李靖. 变应原气道激发在变应性鼻炎和哮喘研究中的作用研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 42-48.
[4] 余洪猛,刘琢扶,戴琪. 合并哮喘的慢性鼻-鼻窦炎的鼻内镜手术治疗[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 38-41.
[5] 邵洁. 探讨儿童过敏性哮喘的若干问题[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 25-27.
[6] 刘传合. 我国儿童哮喘患病与诊治现状[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 28-32.
[7] 邱前辉,高俊潇. 特异性免疫治疗对过敏性鼻炎和哮喘的同步控制和远期疗效[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 33-37.
[8] 沙莉,刘传合. 生物制剂治疗支气管哮喘的研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 53-58.
[9] 洪海裕, 许光福, 杨烁伟,苏荣飞,黄伊厘,池梦诗,王玮豪,杨钦泰. 探究广东地区变应性鼻炎合并支气管哮喘的危险因素[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 94-98.
[10] 王亚坤,张宇,宋西成. 不伴有下气道疾病的慢性鼻-鼻窦炎患者肺功能及相关因素分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 99-102.
[11] 刘杰,曲辉,鹿道温,辛华秀,郭艳丽. 青岛市西部城区春季花粉症调查分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 70-72.
[12] 关乐静综述, 张亚梅审校. 阻塞性睡眠呼吸暂停低通气综合征对儿童肺功能的影响[J]. 山东大学耳鼻喉眼学报, 2016, 30(5): 75-80.
[13] 屠燕怡,史丽,赵莉,金鹏,訾晓雪,李昂,金义炫,郅莉莉. 尘螨疫苗皮下注射治疗变应性鼻炎的疗效和安全性评估[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 50-55.
[14] 杨美艳. 变应性鼻炎伴哮喘患者经微波治疗后的肺功能及呼吸阻力改变[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 82-84.
[15] 晋舒. 全喉切除术后气管感染对喉癌患者肺功能及肿瘤复发率的影响[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 37-39.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 汪晓锋,林 昶,程金妹 . 不同龄小鼠内耳中ABAD的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 207 -211 .
[2] 刘 艳,刘新义,王金平,李大健 . 后鼓室解剖结构测量观察及临床意义[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 218 -221 .
[3] 于青青 综述,王跃建 审校 . 硬质耳内镜的临床应用进展[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 222 -224 .
[4] 杨淑娟,袁 英,刘付星,秦海平 . 美宝湿润烧伤膏联合蛋膜贴补治疗外伤性鼓膜穿孔40例[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 227 -227 .
[5] 林峰,梁勇,卢永田,万丽霞 . 鼻内翻性乳头状瘤临床分型和术式选择[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 231 -233 .
[6] 于志良,王卫卫,王明华 . 耳鼻喉综合动力系统切除会厌囊肿23例[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 278 -279 .
[7] 殷国华,钟 笑 . 激光减容术治疗舌扁桃体肥大的远期疗效[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 280 -282 .
[8] 蔡 谦,苏振忠,文卫平,柴丽萍,叶 辉,滕以书,吴 旋 . 成人打鼾与口咽腔狭窄评分的相关性[J]. 山东大学耳鼻喉眼学报, 2008, 22(4): 289 -292 .
[9] 孙 岩,张庆泉,张 华,宋西成,赵利敏,王 艳,姜绍红,王 强 . 异种（牛）脱细胞真皮基质修复膜在耳鼻咽喉头颈外科术后缺损修复的应用[J]. 山东大学耳鼻喉眼学报, 2008, 22(4): 316 -319 .
[10] 马 敬,刘 斌 . 2450MHz微波辐照对人鼻咽癌细胞增殖与细胞周期的影响[J]. 山东大学耳鼻喉眼学报, 2008, 22(4): 310 -312 .
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发